Coadministration of Phenytoin and Felbamate : Evidence of Additional Phenytoin Dose-Reduction Requirements Based on Pharmacokinetics and Tolerability with Increasing Doses of Felbamate
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-08-01
著者
-
Sachdeo Rajesh
Robert Wood Johnson Medical School Department Of Neurology
-
Sachdeo S.
Robert Wood Johnson Medical School Department Of Neurology
-
Rosenberg A.
Wallace Laboratories Clinical Research
-
SHUMAKER R.
ALPHARMA, Johns Hopkins Bayview Campus
-
SACHDEO R.
Robert Wood Johnson Medical School, Department of Neurology
-
WAGNER M.
Rutgers University College of Pharmacy, Department of Pharmaceutical Practice
-
LYNESS W.
Wallace Laboratories, Clinical Research
-
WARD D.
Synthelabo, Regulatory Affairs
-
PERHACH J.
Wallace Laboratories, Clinical Research
-
Lyness W.
Wallace Laboratories Clinical Research
-
Perhach J.
Wallace Laboratories Clinical Research
-
Shumaker R.
Alpharma Uspd
-
Wagner M.
Rutgers University College Of Pharmacy Department Of Pharmaceutical Practice
-
Ward D.
Synthelabo Regulatory Affairs
関連論文
- Tolerability and Pharmacokinetics of Monotherapy Felbamate Doses of 1,200-6,000mg/day in Subjects with Epilepsy
- Coadministration of Phenytoin and Felbamate : Evidence of Additional Phenytoin Dose-Reduction Requirements Based on Pharmacokinetics and Tolerability with Increasing Doses of Felbamate